定增终止

Search documents
欧林生物: 成都欧林生物科技股份有限公司第七届董事会第四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-31 10:13
成都欧林生物科技股份有限公司 第七届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码:688319 证券简称:欧林生物 公告编号:2025-041 一、董事会会议召开情况 成都欧林生物科技股份有限公司(以下简称"公司")于 2025 年 8 月 29 日以 现场及通讯方式在公司会议室召开第七届董事会第四次会议(以下简称"本次会 议")。经全体董事同意,本次会议豁免通知时限要求。本次会议由公司董事长 樊绍文先生召集并主持,应出席董事 9 人,实际出席会议董事 9 人。本次会议的 通知、召开及审议程序符合《中华人民共和国公司法》《上海证券交易所科创板 股票上市规则》等法律法规、规范性文件及《成都欧林生物科技股份有限公司章 程》(以下简称"《公司章程》")的有关规定,会议决议合法有效。 二、董事会会议审议情况 经与会董事审议,本次会议通过如下议案: (一)审议通过了《关于终止以简易程序向特定对象发行 A 股股票事项并 撤回申请文件的议案》 本次终止以简易程序向特定对象发行股票事项,系公司根据实际 ...
华业香料终止定增 实控人正拟减持首季一致行动人减持
Zhong Guo Jing Ji Wang· 2025-08-27 07:58
Core Viewpoint - Huaye Spice has decided to terminate the plan for a simplified procedure to issue shares to specific targets for the year 2025, which was initially intended to raise a total of 113 million yuan for the first phase of a spice production project [1][2] Group 1: Termination of Share Issuance - The decision to terminate the share issuance was made after careful consideration of the company's current situation and future development plans, following discussions with relevant parties [2] - The company will continue to advance the construction of the 1,300-ton spice production facility using its own and self-raised funds [2] - The termination of the share issuance will not have a significant adverse impact on the company's operations and business development [2] Group 2: Shareholder Reduction Plans - The controlling shareholder and actual controller, Hua Wenliang, plans to reduce his holdings by up to 2,243,940 shares, accounting for 3% of the total share capital [3] - The reduction will occur within three months after the announcement, with a maximum of 1% through centralized bidding and 2% through block trading [3] Group 3: Financial Performance - In the first half of 2025, Huaye Spice achieved operating revenue of 192 million yuan, a year-on-year increase of 11.05% [5] - The net profit attributable to shareholders was 20.9965 million yuan, representing a year-on-year growth of 52.76% [5] - The net profit after deducting non-recurring gains and losses was 21.0989 million yuan, showing a significant increase of 76.63% year-on-year [6]